Beth Israel Medical Center — Boston, Massachusetts

Public research footprint of Beth Israel Medical Center, compiled from the ClinicalTrials.gov public registry.

404

Registered studies

Active

Recruiting now

276

Completed

Stopped or withdrawn

Most-studied conditions

Botryoid-Type Embryonal Rhabdomyosarcoma · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Spindle Cell Rhabdomyosarcoma · Breast Cancer

Recently updated registry entries

NCT05099003 — A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed… (Recruiting)
NCT04089358 — Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young… (Active Not Recruiting)
NCT01547741 — Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Beth Israel Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.